In addition, before starting the pharmacological treatment of Parkinson’s disease, it is important to consider the gender and the presence of genetic variants in MAO-B and COMT genes (MAO-B-rs1799836 and COMT-rs4680), since the outcome is affected by sexual dimorphism in genes related to dopamine metabolism [80]. This evidence concerns the gene COMT and Parkinson disease.